Prof. Dr. Peter Gmeiner

Lehrstuhl für Pharmazeutische Chemie

Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor (2022) Fink EA, Xu J, Hübner H, Braz JM, Seemann P, Avet C, Craik V, et al. Journal article Photochromic Fentanyl Derivatives for Controlled mu-Opioid Receptor Activation (2022) Lahmy R, Hübner H, Schmidt M, Lachmann D, Gmeiner P, König B Journal article The Bitter Taste Receptor TAS2R14 as a Drug Target (2022) Waterloo L, Löber S, Gmeiner P Journal article Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors (2022) Einsiedel J, Schmidt M, Hübner H, Gmeiner P Journal article Structural insights into ligand recognition, activation, and signaling of the α2Aadrenergic receptor (2022) Xu J, Cao S, Hübner H, Weikert D, Chen G, Lu Q, Yuan D, et al. Journal article Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists (2022) Wang H, Hetzer F, Huang W, Qu Q, Meyerowitz J, Kaindl J, Hübner H, et al. Journal article Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer (2021) Budzinski J, Maschauer S, Kobayashi H, Couvineau P, Vogt H, Gmeiner P, Roggenhofer A, et al. Journal article Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles (2021) Wenk D, Ignatchenko V, Macklin A, Hübner H, Gmeiner P, Weikert D, Pischetsrieder M, Kislinger T Journal article Optimizing the expression of human dopamine receptors in escherichia coli (2021) Boritzki V, Hübner H, Allikalt A, Gmeiner P, Wöhrl BM Journal article Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M2R selectivity (2021) Weinhart CG, Wifling D, Schmidt M, Neu E, Höring C, Clark T, Gmeiner P, Keller M Journal article